% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Kapitza:282426,
author = {L. Kapitza$^*$ and N. Ho and T. Kerzel and A. M. Frank and
F. B. Thalheimer and A. Jamali and T. Schaser and C. J.
Buchholz$^*$ and J. Hartmann},
title = {{CD}62{L} as target receptor for specific gene delivery
into less differentiated human {T} lymphocytes.},
journal = {Frontiers in immunology},
volume = {14},
issn = {1664-3224},
address = {Lausanne},
publisher = {Frontiers Media},
reportid = {DKFZ-2023-01753},
pages = {1183698},
year = {2023},
abstract = {Chimeric antigen receptor (CAR)-expressing T cells are a
complex and heterogeneous gene therapy product with variable
phenotype compositions. A higher proportion of less
differentiated CAR T cells is usually associated with
improved antitumoral function and persistence. We describe
in this study a novel receptor-targeted lentiviral vector
(LV) named 62L-LV that preferentially transduces less
differentiated T cells marked by the L-selectin receptor
CD62L, with transduction rates of up to $70\%$ of CD4+ and
$50\%$ of CD8+ primary T cells. Remarkably, higher amounts
of less differentiated T cells are transduced and preserved
upon long-term cultivation using 62L-LV compared to VSV-LV.
Interestingly, shed CD62L neither altered the binding of
62L-LV particles to T cells nor impacted their transduction.
The incubation of 2 days of activated T lymphocytes with
62L-LV or VSV-LV for only 24 hours was sufficient to
generate CAR T cells that controlled tumor growth in a
leukemia tumor mouse model. The data proved that potent CAR
T cells can be generated by short-term ex vivo exposure of
primary cells to LVs. As a first vector type that
preferentially transduces less differentiated T lymphocytes,
62L-LV has the potential to circumvent cumbersome selections
of T cell subtypes and offers substantial shortening of the
CAR T cell manufacturing process.},
keywords = {CAR T cells (Other) / L-selectin (Other) / LV (Other) /
chimeric antigen receptor (Other) / naïve T lymphocytes
(Other) / receptor-targeted viral vectors (Other) / ΔLNGFR
(Other)},
cin = {HD01 / FM01},
ddc = {610},
cid = {I:(DE-He78)HD01-20160331 / I:(DE-He78)FM01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37646032},
pmc = {pmc:PMC10461316},
doi = {10.3389/fimmu.2023.1183698},
url = {https://inrepo02.dkfz.de/record/282426},
}